Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Motiva breast implants to use VeriTeQ’s heat-resistant UDI microchip

VeriTeQ : 08 August, 2013  (Company News)
Digital Angel, a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition, is partnering with Establishment Labs, SA, d/b/a Motiva, to market the world's first traceable breast implant with Q Inside.

The traceable breast implant enables a manufacturer, physician or patient to access a secure online database and retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data.

In September 2012, VeriTeQ entered into a development and supply agreement with EL, a global provider of breast implants under the Motiva Implant Matrix brand name, to build next-generation breast implants that contain VeriTeQ's Unique Device Identifier (UDI) called 'Q Inside'.

"With our FDA cleared Q Inside technology, we believe we offer the only solution of its kind that is currently available to meet the FDA’s Proposed Rule for the unique device identification of implantable medical devices," said Scott Silverman, Chairman and Chief Executive Officer of Digital Angel. "We are very pleased to work with EL, an innovative company with a forward-thinking management team on the cutting edge of healthcare technology."

The FDA's Proposed Rule for UDI reflects in 801.50 a direct marking requirement recommended for implantable medical devices because these devices present risks that would be better controlled through such a direct marking (versus simple labelling on the outside of the medical device packaging). The UDI Regulation has been released from the FDA to the White House Office of Management and Budget, and the final review is currently underway. It is anticipated that the final UDI Regulation will be released in the near future.

VeriTeQ's Q Inside, a passive radio frequency identification (RFID) microchip, enables implantable medical devices to be quickly and safely identified from outside the body. Q Inside is a direct marking technology that provides Automatic Identification and Data Capture technology as required for implantable medical devices under the FDA's Proposed Rule for UDI.

According to the International Society of Aesthetic Plastic Surgery, the number of breast augmentation procedures performed worldwide in 2011 exceeded 1.2 million.

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo